Table 2:
Clinical picture of 28 evaluable cases of the study
Clinical symptoms |
Total cases (28 cases) |
(Gem-Ox) (12 cases) |
(Gem-Ox-Pem) (16 cases) |
P Value |
|
Central lung lesions |
|||||
|
Dyspnea |
15 (53.6%) |
8 (66.7%) |
7 (43.8%) |
0.21 |
Hemoptysis |
10 (35.7%) |
4 (33.3%) |
6 (37.5%) |
0.3 |
|
Dysphagia |
1 (3.6%) |
- |
1 (6.3%) |
0.57 |
|
Hoarseness |
2 (7.1%) |
- |
2 (12.5%) |
0.32 |
|
Peripheral lung lesions |
|||||
|
Cough |
21 (75%) |
9 (75%) |
12 (75%) |
0.67 |
Dyspnea |
12 (42.9%) |
6 (50%) |
6 (37.5%) |
0.24 |
|
Chest
pain |
8 (28.6%) |
3 (25%) |
5 (31.3%) |
0.31 |
|
Central lung lesions |
|||||
|
Bony
pains |
14 (50%) |
6 (50%) |
8 (50%) |
0.3 |
Jaundice |
5 (17.9%) |
3 (25%) |
2 (12.5%) |
0.36 |
|
Neurological |
3 (10.7%) |
2 (16.7%) |
1 (6.3%) |
0.39 |
Gem, gemcitabine ;
Ox, oxaliplatin;
Pem, pemetrexed.